171 related articles for article (PubMed ID: 37616205)
1. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes.
Schwarz M; Schwarz C; Burghart L; Pfisterer N; Bauer D; Hübl W; Mandorfer M; Gschwantler M; Reiberger T
PLoS One; 2023; 18(8):e0290352. PubMed ID: 37616205
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
[TBL] [Abstract][Full Text] [Related]
3. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
[TBL] [Abstract][Full Text] [Related]
4. The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study.
Wang X; Wei S; Wei Y; Wang X; Xiao F; Feng Y; Zhu Q
Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):889-898. PubMed ID: 37395242
[TBL] [Abstract][Full Text] [Related]
5. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study.
Pereira GH; Peixoto HR; Giusti ML; Souza ML; Victor LB; Fernandes F; Perez RM; Villela-Nogueira CA
Braz J Infect Dis; 2022; 26(5):102697. PubMed ID: 36037847
[TBL] [Abstract][Full Text] [Related]
7. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
[TBL] [Abstract][Full Text] [Related]
8. [Hepatic transit times and liver elasticity compared with meld in predicting a 1 year adverse clinical outcome of a clinically diagnosed cirrhosis].
Koller T; Piešťanská Z; Hlavatý T; Holomáň J; Glasa J; Payer J
Vnitr Lek; 2016; 62(5):351-9. PubMed ID: 27319227
[TBL] [Abstract][Full Text] [Related]
9. Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study.
Fujiyama S; Akuta N; Sezaki H; Kobayashi M; Kawamura Y; Hosaka T; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Ikeda K; Kumada H
BMC Gastroenterol; 2021 Apr; 21(1):189. PubMed ID: 33892649
[TBL] [Abstract][Full Text] [Related]
10. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
[TBL] [Abstract][Full Text] [Related]
11. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.
Torp N; Israelsen M; Madsen B; Lutz P; Jansen C; Strassburg C; Mortensen C; Knudsen AW; Sorensen GL; Holmskov U; Schlosser A; Thiele M; Trebicka J; Krag A
JHEP Rep; 2021 Jun; 3(3):100287. PubMed ID: 34041469
[TBL] [Abstract][Full Text] [Related]
12. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
El-Sherif O; Jiang ZG; Tapper EB; Huang KC; Zhong A; Osinusi A; Charlton M; Manns M; Afdhal NH; Mukamal K; McHutchison J; Brainard DM; Terrault N; Curry MP
Gastroenterology; 2018 Jun; 154(8):2111-2121.e8. PubMed ID: 29535028
[TBL] [Abstract][Full Text] [Related]
13. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.
Kim JJ; Kim JH; Koo JK; Choi YJ; Ko SY; Choe WH; Kwon SY
Clin Mol Hepatol; 2014 Mar; 20(1):47-55. PubMed ID: 24757658
[TBL] [Abstract][Full Text] [Related]
14. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
[TBL] [Abstract][Full Text] [Related]
15. Natural history of compensated viral B and D cirrhosis.
Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
[TBL] [Abstract][Full Text] [Related]
16. Effect of alcohol on clinical complications of hepatitis virus-induced liver cirrhosis: a consecutive ten-year study.
Abassa KK; Wu XY; Xiao XP; Zhou HX; Guo YW; Wu B
BMC Gastroenterol; 2022 Mar; 22(1):130. PubMed ID: 35305565
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.
Rinaldi L; Nascimbeni F; Giordano M; Masetti C; Guerrera B; Amelia A; Fascione MC; Ballestri S; Romagnoli D; Zampino R; Nevola R; Baldelli E; Iuliano N; Rosato V; Lonardo A; Adinolfi LE
World J Gastroenterol; 2017 Feb; 23(8):1458-1468. PubMed ID: 28293093
[TBL] [Abstract][Full Text] [Related]
18. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
[TBL] [Abstract][Full Text] [Related]
19. Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.
Jang JW; Choi JY; Kim YS; Yoo JJ; Woo HY; Choi SK; Jun CH; Lee CH; Sohn JH; Tak WY; Lee YR; Han KH
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1954-1963.e3. PubMed ID: 29753085
[TBL] [Abstract][Full Text] [Related]
20. Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosis.
Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
Scand J Gastroenterol; 2018 Apr; 53(4):475-481. PubMed ID: 29513096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
